Overview

Safety and Efficacy Study of Parkinson's Disease Gene Therapy Drug (BBM-P002)

Status:
Not yet recruiting
Trial end date:
2028-12-30
Target enrollment:
Participant gender:
Summary
Safety and Efficacy Study of BBM-P002 in subjects with primary advanced Parkinson's disease
Phase:
Early Phase 1
Details
Lead Sponsor:
Xiangya Hospital of Central South University